Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules with potential antitumor and antimicrobial properties. It serves as a building block in organic reactions where the bromoacetamide group acts as an alkylating agent, enabling the formation of carbon-nitrogen bonds in heterocyclic systems. Its electron-withdrawing trifluoromethylphenyl group enhances stability and influences the reactivity of the molecule, making it valuable in medicinal chemistry for designing enzyme inhibitors and receptor ligands. Also employed in research settings for the preparation of fluorescent probes and labeled compounds due to its favorable reactivity profile.